Altered Faecal Protease Activity in Irritable Bowel Syndrome Patients in China
1 other identifier
observational
60
0 countries
N/A
Brief Summary
Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder haracterised by abdominal pain or discomfort associated with altered bowel habits,while the mechanism is still not understood.Recent advances have conceptualized the faecal supernatants of diarrhoea-predominant IBS have a substantially higher serine protease activity, while in china,almost no studies have reported about protease activity in IBS.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2010
CompletedFirst Submitted
Initial submission to the registry
February 1, 2010
CompletedFirst Posted
Study publicly available on registry
February 2, 2010
CompletedFebruary 2, 2010
January 1, 2010
February 1, 2010
February 1, 2010
Conditions
Keywords
Study Arms (3)
IBS-D
IBS-C
Controll
Eligibility Criteria
Outpatients in the second affiliated hospital of xi'an jiaotong university
You may qualify if:
- Patients fulfilling the Rome III criteria for IBS participated in the study -
You may not qualify if:
- Organic gastrointestinal disorders were excluded by detailed blood and stool analyses, serological assays and colonoscopy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
February 1, 2010
First Posted
February 2, 2010
Study Start
January 1, 2010
Last Updated
February 2, 2010
Record last verified: 2010-01